Upon implantation into syngeneic mice, TEAD3 deficiency led to a pronounced reduction in tumor growth (Supplementary Figure S2C–D) and attenuated EMT markers in IHC analysis (Supplementary Figure S2E), corroborating the results obtained with the B16F10luc model. This evidence concerns the gene TEAD3 and neoplasm.